Clinical Trials Logo

Metabolic Diseases clinical trials

View clinical trials related to Metabolic Diseases.

Filter by:

NCT ID: NCT03550365 Completed - Inflammation Clinical Trials

Grain Fibre and Gut Health

FIBREFECTS
Start date: January 1, 2011
Phase: N/A
Study type: Interventional

Wholegrain fibre is known to affect on the gut health, but also may cause intestinal discomfort. Thus, many individuals may avoid the consumption of whole grain cereals in spite of their known health benefits, and may in this regard consume more restricted diets. In the preset study the aim was to technologically modify the cereal fibres to improve its usability and to maintain its health beneficial properties. The objective was to investigate intestinal fermentation of grain dietary fibre and associated effects on gut-mediated metabolic health, such as immunological health and adipose tissue function. The hypothesis was that whole grain products maintain their original beneficial health effects and may be better tolerable when the bran is technologically modified. Additionally, it was hypothesized that gut-mediated bioavailability of plant cell wall compounds and their metabolites affect the metabolic health through their immunomodulatory effects.

NCT ID: NCT03550105 Completed - Diabetes Mellitus Clinical Trials

Effects of Simulated Passive Jogging Device on Glucose Homeostasis, Muscle Strength and Endurance

Start date: June 5, 2018
Phase: N/A
Study type: Interventional

Physical Inactivity and excessive sedentary behavior are risk factors for diabetes and cardiovascular disease. Movement is important for overall health. This study will assess the validity and usefulness of low risk, non-invasive wellness device, the Gentle Jogger® (GJ) that passively simulates the physical activities of jogging. The study will evaluate whether or not use of GJ modifies glycemic control and muscle strength in subjects who are known to be diabetic and those who are not. The study volunteers are subjects between the ages of 25-80yr.

NCT ID: NCT03545009 Completed - Obesity Clinical Trials

Determination of the Independent Effects of Beetroot Juice Components, Dietary Nitrate and Antioxidants, on Exercise Tolerance and Health Benefits in Individuals With Obesity

BEETIT
Start date: August 10, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effects of acute beetroot juice supplementation on exercise performance and cardiometabolic health in obese individuals with secondary cardiometabolic complications. Additionally, we will determine if the ergogenic health benefits of beetroot juice is due to the nitric oxide compound within the product, the antioxidant compound within the product, or a combination of the two compounds.

NCT ID: NCT03543540 Completed - Celiac Disease Clinical Trials

Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease

Start date: May 1, 2018
Phase: Phase 1
Study type: Interventional

A randomized, double-blind, placebo-controlled clinical study in non-homozygous human leukocyte antigen (HLA)-DQ.2.5+ adults with celiac disease (CeD).

NCT ID: NCT03525431 Completed - Epilepsy Clinical Trials

Clinical Utility of Pediatric Whole Exome Sequencing

Start date: August 1, 2017
Phase: N/A
Study type: Interventional

The investigator aims to examine the clinical utility of WES, including assessment of a variety of clinical outcomes in undiagnosed pediatric cases.

NCT ID: NCT03520725 Completed - Clinical trials for Nutritional and Metabolic Disease

Antioxidant Capacity and Vitamin A Profile in Young Adults Who Consume a Snack Bar Made From Tropical Fruits Treated With UV-C

Start date: December 2016
Phase: N/A
Study type: Interventional

The objective of the present study was to evaluate the impact of a snack bar on some health indicators associated with diet (plasma antioxidant capacity, lipid profile, vitamin A profile (retinol and carotenoids)) and on the nutritional status (impact on energy and nutrients consumed) in a group of upper level students.

NCT ID: NCT03503747 Completed - Diabetes Mellitus Clinical Trials

Investigating Genetic Risk for Type 1 Diabetes

INGR1D
Start date: April 25, 2018
Phase:
Study type: Observational

The objective of this study is to determine the percentage of children with genetic markers putting them at increased risk of developing type 1 diabetes, and to offer the opportunity for these children to be enrolled into a phase II b primary prevention trial.

NCT ID: NCT03489538 Completed - Clinical trials for Bariatric Surgery Candidate

Homocysteine After Laparoscopic Roux-enY Gastric Bypass

Start date: April 9, 2013
Phase:
Study type: Observational

Changes in homocysteine values after bariatric surgery remain controversially discussed. This is the first comprehensive summary to depict timeline changes in homocysteine levels following laparoscopic roux-en-Y gastric bypass.

NCT ID: NCT03486223 Completed - Obesity Clinical Trials

Soluble Epoxide Hydrolase Inhibition and Insulin Resistance

Start date: May 17, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to test how soluble epoxide hydrolase (sEH) inhibition with GSK2256294 affects tissue sEH activity and insulin sensitivity.

NCT ID: NCT03451994 Completed - Clinical trials for Nutritional and Metabolic Diseases

Exploratory Study of Volatile Organic Compounds in Alveolar Breath

VOCs
Start date: October 1, 2011
Phase:
Study type: Observational

The purpose of this secondary analysis is to identify breath signatures associated with idiopathic malodor conditions.